Ad
related to: amgenscbn.org has been visited by 10K+ users in the past month
Search results
Cathie Wood's ARK sells Robinhood, buys UiPath and Amgen stock By Investing.com
Investing.com· 1 day agoCathie Wood's ARK sells Robinhood, buys UiPath and Amgen stock
Should you buy Amgen’s stock above $300? | Invezz
Invezz· 13 hours agoAmgen Inc. (NASDAQ:AMGN) has recently been in the news due to its involvement in the promising obesity drug market. The U.S. FDA has approved Amgen’s...
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 5 days agoAmgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
It's Unlikely That Amgen Inc.'s (NASDAQ:AMGN) CEO Will See A Huge Pay Rise This Year
Simply Wall St. via Yahoo Finance· 7 days agoKey Insights Amgen to hold its Annual General Meeting on 31st of May CEO Bob Bradway's total...
Where Will Amgen Be in 3 Years?
Motley Fool via Yahoo Finance· 3 days agoIf you're looking for an investment in the pharmaceutical sector and you don't already own shares of Amgen (NASDAQ: AMGN), it might be worth considering...
US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment
Reuters via AOL· 3 days agoAmgen's drug will be marketed under the name Bkemv. Biosimilars are close copies of complex...
Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?
Motley Fool via Yahoo Finance· 6 days agoWith some promising clinical trial results in hand and more that could be on the way relatively...
Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug
Benzinga via Yahoo Finance· 2 days agoTuesday, the FDA approved Amgen Inc (NASDAQ:AMGN) Bkemv (eculizumab-aeeb) as the first...
AMGEN Inc. (AMGN) Shares Plummet Below 1-Year High – News Heater
NewsHeater· 2 days agoThe stock of AMGEN Inc. (NASDAQ: AMGN) has decreased by -1.27 when compared to last closing price of 300.19. Despite this, the company has experienced a -5.87% fall in its ...
FDA approves Amgen’s interchangeable biosimilar Bkemv
Pharmaceutical Technology via Yahoo Finance· 3 days agoThe US Food and Drug Administration (FDA) has approved Amgen's Bkemv (eculizumab-aeeb) as the first...